These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7984829)

  • 1. Multiple sclerosis: pathogenesis and treatment.
    Bansil S; Troiano R; Rohowsky-Kochan C; Jotkowitz A; Dowling PC; Cook SD
    Semin Neurol; 1994 Jun; 14(2):146-53. PubMed ID: 7984829
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon therapy of multiple sclerosis].
    Jensen D
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status of the problem of disseminated sclerosis].
    Kanareĭkin KF; Bakhur VT
    Klin Med (Mosk); 1985 Sep; 63(9):12-9. PubMed ID: 2415750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interferon beta-1b. New therapy for patients with secondary progressive multiple sclerosis].
    Nervenarzt; 1999 May; 70(5 Suppl):1-12. PubMed ID: 10368803
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon beta produces only small benefits in multiple sclerosis.
    McKee L
    BMJ; 1998 May; 316(7142):1410. PubMed ID: 9616008
    [No Abstract]   [Full Text] [Related]  

  • 6. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?
    Kaminski N; Achiron A
    PLoS Med; 2005 Feb; 2(2):e33; quiz e51. PubMed ID: 15736992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis update.
    Mayr WT; Rodriguez M
    Minn Med; 2002 Jun; 85(6):36-9. PubMed ID: 12092437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of multiple sclerosis--1. New drugs may be effective but there still are frequent relapses].
    Svenningsson A; Andersson M; Olsson T
    Lakartidningen; 1998 Dec; 95(49):5623-7, 5630. PubMed ID: 9863300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon beta in the treatment of multiple sclerosis--closing remarks.
    Kappos L
    Mult Scler; 1995; 1 Suppl 1():S64-6. PubMed ID: 9345403
    [No Abstract]   [Full Text] [Related]  

  • 11. The challenge of managing patients with multiple sclerosis.
    MacLean R
    Nurs Times; 2004 Jan 27-Feb 2; 100(4):42-4. PubMed ID: 14974264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How much can we learn from long-term extension trials in multiple sclerosis?
    Noseworthy JH
    Neurology; 2006 Sep; 67(6):930-1. PubMed ID: 17000954
    [No Abstract]   [Full Text] [Related]  

  • 14. [Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using methods of reflexotherapy].
    Chupryna HM; Murashko NK
    Lik Sprava; 2012; (7):198-204. PubMed ID: 23350151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific treatment of multiple sclerosis.
    Silberberg DH
    Clin Neurosci; 1994; 2(3-4):271-4. PubMed ID: 7749898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: advances, excitements, disenchantments.
    Kieseier BC; Wiendl H
    Lancet Neurol; 2006 Jan; 5(1):2-3. PubMed ID: 16361006
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis].
    de Haan RJ; Polman CH
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2168-71. PubMed ID: 8984352
    [No Abstract]   [Full Text] [Related]  

  • 18. Repeated intervals of high-dose corticosteroid: an overlooked therapy in multiple sclerosis.
    Johnson LN; Morey SS
    Mo Med; 2005; 102(1):47-50. PubMed ID: 15754617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis.
    Horowski R; Stürzebecher CS; Kapp JF
    Funct Neurol; 2001; 16(2):117-28. PubMed ID: 11495417
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multiple sclerosis in a female patient].
    Elovaara I; Kuusisto H
    Duodecim; 2003; 119(21):2037-43. PubMed ID: 14655534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.